Durham, NC - An initial dose of 162-mg aspirin may be as effective as and perhaps safer than 325 mg for the acute treatment of ST-elevation MI (STEMI), a new study suggests [1]. The study, published ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Please provide your email address to receive an email when new articles are posted on . Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to ...

(UPDATED) Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, ...

Please provide your email address to receive an email when new articles are posted on . The ADAPTABLE trial, presented and published in May, was notable in two ways: It provided answers on aspirin ...

Aspirin, in high doses from 900 to 1300 mg, was shown to be an effective and safe treatment option for acute migraine headaches, with further research showing its potential efficacy in preventing ...

Not long ago, aspirin was viewed primarily as a means of providing relief from minor aches, pains, and fevers. But as evidence mounted in support of aspirin’s preventive powers, this medicine-chest ...

December 20, 2007 (Durham, NC) – An initial dose of 162-mg aspirin may be as effective as and perhaps safer than 325 mg for the acute treatment of ST-elevation MI (STEMI), a new study suggests [ 1].